57.5

Tara Pritchard

Malaghan Institute of Medical Research

Tara Pritchard's research has significantly contributed to our understanding and treatment of various cancers, including breast cancer and leukemia. Their work on glycolipid-peptide conjugate vaccines showed promise in eliciting effective CD8+ T-cell responses and preventing metastasis. Additionally, studies on raloxifene nano-micelles revealed their potential in targeting estrogen receptor-β and epidermal growth factor receptor to combat triple-negative breast cancer. Pritchard also investigated the effects of obi-3424, a novel prodrug, against preclinical models of T-cell acute lymphoblastic leukemia (T-ALL), and found that it exhibited potent efficacy.

Firms applying this knowledge

The Regents Of The University Of Michigan

Commercial signal 57.3
Scientific signal 59.2
Social signal 58.1
Papers 7
2 Patent-to-paper cites
332 Paper cites

scientifiq.ai is an experimental platform. The platform relies on open source data and it may contain errors. Its primary goal is to advance scientific research on innovation.